Drugmakers Push Back Against Canada’s New Pricing…
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory body to reconsider their…
Tagged with Canada
Alzheimer’s Disease Treatment: Canadian-Led Innovation…
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for Alzheimer’s Disease (AD)…
Global Pharma has Reinvented R&D: Will Canadian Start-Ups…
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global…
A New Approach to Rare Diseases in Canada
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to better tackle rare diseases in Canada.…
Biogen Canada’s Marina Vasiliou: A 100% Commitment to…
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of…
Biosimilars and Biologics: Canada
Biosimilars and biologics in Canada: A legal guide. Prepared in association with Fasken, a leading global law firm, this is an extract from The…
Localization: Canada
Want to know more about the localization in Canada? Read on! Prepared in association with Fasken, a leading global law firm, this is an extract…
Orphan Drugs and Rare Diseases: Canada
All legal aspects surrounding orphan drugs and rare diseases in Canadian Pharma. Prepared in association with Fasken, a leading global law firm, this…
Collective Impact in the Health Charity Sector
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger…
Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial for companies hoping to succeed in…
NEW Update to Health Canada’s Policy: The Distinction Between…
It is not a secret anymore, many in the industry now know that Health Canada is working on a new version of the policy entitled: The Distinction…
Comprehensive Access to Medicines should be the Priority for…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of prescription drugs. With a new…
